American journal of otolaryngology · 2026
Inferior turbinate reduction for refractory pediatric allergic rhinitis: Symptom control and sleep-related quality of life outcomes.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hosri Jad, Abou Chaar Jonathan, Ghadieh Justin, Daou Anne-Marie, Abou Raji Feghali Patrick, Korban Zeina, Barazi Randa
Аннотация
OBJECTIVE: To compare symptom control, sinonasal and sleep-related quality of life in children with refractory allergic rhinitis treated with inferior turbinate reduction versus medical therapy.
DESIGN: This is a prospective cohort pilot study.
POPULATION: Children aged 5-17 years with a documented allergic rhinitis refractory to 3 months of medical therapy, were recruited. The study group consisted of children who underwent surgery and the control group included children who remained on medical therapy.
PRIMARY OUTCOMES: Three questionnaires pertaining to the sinus and nasal quality of life (SN-5), obstructive sleep apnea symptoms (OSA-18), and nasal obstruction symptom evaluation (NOSE) were collected before and after intervention at 1 and 3 months. Flexible endoscopic findings of disease regression before and after intervention were also mentioned.
RESULTS: Thirty-four subjects were recruited, 17 of whom underwent surgery and 17 who received medical therapy. At 1 month follow-up, the mean drop in the questionnaires' scores (SN-5; OSA-18; NOSE) was greater in the study group (9.9 ± 5.8; 23.2 ± 9.8, 8.2 ± 3.8, respectively) compared to the control group (6.8 ± 3.9, 17.3 ± 7.1, 4.6 ± 2.8, respectively). The difference in symptoms improvement between the two groups was a statistically significant in all three questionnaires (p = 0.029; p = 0.037; p = 0.005; respectively). Similar results were obtained at 3 months follow-up. Almost all patients in the surgery group (88.2%) had complete disease regression in comparison to only 29.4% in the control group (p < 0.001).
CONCLUSION: Introducing surgery to children with refractory allergic rhinitis can significantly improve the patient's symptoms and quality of life.
DESIGN: This is a prospective cohort pilot study.
POPULATION: Children aged 5-17 years with a documented allergic rhinitis refractory to 3 months of medical therapy, were recruited. The study group consisted of children who underwent surgery and the control group included children who remained on medical therapy.
PRIMARY OUTCOMES: Three questionnaires pertaining to the sinus and nasal quality of life (SN-5), obstructive sleep apnea symptoms (OSA-18), and nasal obstruction symptom evaluation (NOSE) were collected before and after intervention at 1 and 3 months. Flexible endoscopic findings of disease regression before and after intervention were also mentioned.
RESULTS: Thirty-four subjects were recruited, 17 of whom underwent surgery and 17 who received medical therapy. At 1 month follow-up, the mean drop in the questionnaires' scores (SN-5; OSA-18; NOSE) was greater in the study group (9.9 ± 5.8; 23.2 ± 9.8, 8.2 ± 3.8, respectively) compared to the control group (6.8 ± 3.9, 17.3 ± 7.1, 4.6 ± 2.8, respectively). The difference in symptoms improvement between the two groups was a statistically significant in all three questionnaires (p = 0.029; p = 0.037; p = 0.005; respectively). Similar results were obtained at 3 months follow-up. Almost all patients in the surgery group (88.2%) had complete disease regression in comparison to only 29.4% in the control group (p < 0.001).
CONCLUSION: Introducing surgery to children with refractory allergic rhinitis can significantly improve the patient's symptoms and quality of life.